Body
EMBARGOED UNTIL 2 P.M. ET, Monday, April 16, Cleveland: A landmark 2016 Cleveland Clinic study of widely used pain-relieving drugs showed that celecoxib (Celebrex) was associated with comparable cardiovascular safety and better gastrointestinal (GI) and kidney safety when compared with either naproxen (Naprosyn) and ibuprofen (Motrin).
MAYWOOD, IL - While antibiotics have greatly reduced the dangers of ear infections, serious neurological complications, including hearing loss, facial paralysis, meningitis and brain abscess still occur, according to a report in the journal Current Neurology and Neuroscience Reports.
The article was written by Loyola Medicine otolaryngologists Michael Hutz, MD, Dennis Moore, MD, and Andrew Hotaling, MD.
In a study of more than 15,000 girls and their mothers -- all Kaiser Permanente members in Northern California -- maternal overweight and hyperglycemia were linked to the earlier onset of puberty in girls 6 to 11 years old. Early puberty has been linked to multiple adverse health developments as girls grow up.
DALLAS, April 16, 2018 -- African Americans who smoke appear to be at far greater risk of developing heart failure than those who never smoked, or those who quit, according to new research in the American Heart Association's journal Circulation.
A phase I, first-in-human study led by The University of Texas MD Anderson Cancer Center reveals for the first time, an investigational drug that is effective and safe for patients with cancers caused by an alteration in the receptor tyrosine kinase known as RET. The drug appears to be promising as a potential therapy for RET-driven cancers, such as medullary and papillary thyroid, non-small cell lung, colorectal and bile duct cancers, which have been historically difficult to treat.
HERCULES, Calif. -- April 14, 2018 -- New research showcasing the importance of Bio-Rad's Droplet Digital PCR (ddPCR) technology in clinical applications will be featured in more than 60 presentations at the American Association for Cancer Research (AACR) Annual Meeting in Chicago, April 14-18.
Omega-3 fatty acid supplements taken orally proved no better than placebo at relieving symptoms or signs of dry eye, according to the findings of a well-controlled trial funded by the National Eye Institute (NEI), part of the National Institutes of Health. Dry eye disease occurs when the film that coats the eye no longer maintains a healthy ocular surface, which can lead to discomfort and visual impairment. The condition affects an estimated 14 percent of adults in the United States. The paper was published online April 13 in the New England Journal of Medicine.
PHILADELPHIA - More than 16 million Americans suffer from dry eye, an often chronic condition that causes burning, itching, or stinging sensations in the eye, as well as impaired vision. For years, patients and their eye doctors have turned to omega-3 fatty acids commonly found in fish-derived supplements as a treatment for the disease. Findings from a new randomized clinical trial, now show omega-3 supplements are no more effective than placebo at alleviating dry eye symptoms.
Heat and cold waves affect people with certain health conditions differently, highlighting the need for tailored public service risk communication.
Extreme hot and cold weather increase the number of deaths and emergency room visits but affect specific at-risk populations differently, according to new research from the U.S. and Japan.
13 April 2018, Paris, France: Deep-learning approaches to pattern recognition in liver biopsy samples have moved one step closer to clinical application, with a new study reporting a good correlation between an automated image analysis system and an expert reviewer for the identification of key markers of disease activity in a pre-clinical model of non-alcoholic steatohepatitis (NASH).
CINCINNATI - Scientists used an experimental targeted molecular therapy to block a matrix-forming protein in heart cells damaged by heart attack, reducing levels of scarred muscle tissue and saving mouse models from heart failure.
Regularly drinking more than the recommended UK guidelines for alcohol could take years off your life, according to new research published today in the Lancet. Part-funded by the British Heart Foundation, the study shows that drinking more alcohol is associated with a higher risk of stroke, fatal aneurysm, heart failure and death.
The authors say their findings challenge the widely held belief that moderate drinking is beneficial to cardiovascular health, and support the UK's recently lowered guidelines.
Even the briefest increase in airborne fine particulate matter PM2.5, pollution-causing particles that are about 3 percent of the diameter of human hair, is associated with the development of acute lower respiratory infection (ALRI) in young children, according to newly published research.
Increases in PM2.5 levels also led to increased doctor visits for these lung infections.
Cloud computing, "exhausted" T cells, breast cancer risk in childhood cancer survivors and clinical trial design for CAR-T therapy in solid tumors are among the topics St. Jude Children's Research Hospital investigators will discuss at the five-day American Association for Cancer Research annual meeting that begins Saturday, April 14, in Chicago.
PARIS, 12 April 2018 - An affordable hepatitis C combination treatment including the new drug candidate ravidasvir has been shown to be safe and effective, with extremely high cure rates for patients, including hard-to-treat cases, according to interim results from the Phase II/III STORM-C-1 trial presented by the non-profit research and development organisation Drugs for Neglected Diseases initiative (DNDi) at the